Veracyte (VCYT) Earnings Analysis

Veracyte (VCYT) next reports earnings on 2026-07-30, consensus EPS 0.43 USD. Last quarter (2026-02-25) it beat with EPS 0.53 USD vs 0.4083 USD est (+29.8%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E 52.38.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does VCYT next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate0.43 USD
Revenue estimate0.14B

VCYT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-250.53 USD0.4083 USD+29.8%Beat
2025-02-240.36 USD0.1 USD+260%Beat

Beat rate: 2/2 (100%) over reported quarters with consensus data.

VCYT valuation and analyst view

Trailing P/E52.38
Trailing EPS1.107 USD
Price / book3.43
Dividend yield0.00%
Market cap4.65B
Analyst consensusBuy (14 buy / 6 hold / 1 sell)
Avg price target55.57 USD

Related research pages

Frequently asked questions

When is Veracyte (VCYT)'s next earnings date?

Veracyte is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.43 USD and revenue estimate of 0.14B.

Did VCYT beat earnings last quarter?

In its 2026-02-25 report, VCYT posted EPS of 0.53 USD versus a 0.4083 USD estimate — a beat of 29.8%.

What is VCYT's earnings track record?

Over the last 2 reported quarters with consensus data, VCYT beat estimates 2 times (100%).

What is VCYT's current P/E ratio and EPS?

VCYT trades at a trailing P/E of 52.38 on trailing EPS of 1.1065723062518098 USD.

What do analysts rate VCYT?

Analyst consensus is "Buy" across 21 ratings (0 strong buy, 14 buy, 6 hold, 1 sell, 0 strong sell). Average 12-month price target: 55.57 USD.